Literature DB >> 6603476

Lymphocyte phenotype and function in pseudolymphoma associated with Sjögren's syndrome.

R I Fox, T C Adamson, S Fong, C A Robinson, E L Morgan, J A Robb, F V Howell.   

Abstract

Lymph node (LNL) and salivary gland lymphocytes (SGL) from three patients with pseudolymphoma and primary Sjögren's syndrome (1(0)SS) were characterized with monoclonal antibodies to demonstrate (a) a predominance of T cells (greater than 80%) reactive with anti-T cell antibodies OKT4 (greater than 70%) and OKT8 (less than 20%); (b) a high prevalence of activation antigens (greater than 50% of cells reactive with antibody OKT10 and anti-Ia antibody); (c) polyclonal B cells (8-15% of all cells expressing kappa or lambda); and (d) a specific B cell subset defined by reactivity with antibody B532 that was not present in their peripheral blood. In vitro functional studies showed that both SGL and LNL provided T helper activity for immunoglobulin synthesis and that this activity could be abolished by treatment with antibody OKT4 plus complement. The SGL and LNL exhibited little natural killer, antibody-dependent cellular cytotoxicity, or cytotoxic T cell activity. Normal karyotype was observed in SGL, LNL, and peripheral blood lymphocytes (PBL) from these patients. These findings indicate that pseudolymphoma in 1(0)SS results from the infiltration of salivary glands and extraglandular tissues by nonneoplastic T helper cells. Monoclonal antibodies provide an important tool to distinguish pseudolymphoma from non-Hodgkins (B cell) lymphomas that have a markedly elevated incidence in 1(0)SS patients. Our finding of T helper cells in pseudolymphoma tissues supports the hypothesis that chronic stimulation of B cells by helper T cells leads to eventual escape of a malignant B cell clone.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603476      PMCID: PMC1129160          DOI: 10.1172/jci110984

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Chromosome 14 translocations in non-Burkitt lymphomas.

Authors:  S Fukuhara; J D Rowley
Journal:  Int J Cancer       Date:  1978-07-15       Impact factor: 7.396

Review 2.  The histopathology of Sjögren's syndrome in labial salivary gland biopsies.

Authors:  J S Greenspan; T E Daniels; N Talal; R A Sylvester
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1974-02

3.  Antigen-induced selective recruitment of circulating lymphocytes.

Authors:  J Sprent; J F Miller; G F Mitchell
Journal:  Cell Immunol       Date:  1971-04       Impact factor: 4.868

4.  Sjogren's syndrome. I. Sicca components.

Authors:  K Whaley; J Williamson; D M Chisholm; J Webb; D K Mason; W W Buchanan
Journal:  Q J Med       Date:  1973-04

5.  Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm.

Authors:  J Zulman; R Jaffe; N Talal
Journal:  N Engl J Med       Date:  1978-11-30       Impact factor: 91.245

6.  Letter: Sjögren's syndrome with light chain myeloma.

Authors:  M A Shearn; H M Moutsopoulos; S Sawada; C Gak
Journal:  West J Med       Date:  1975-12

7.  Specific marker chromosome 14 in malignant lymphomas.

Authors:  S Fukuhara; S Shirakawa; H Uchino
Journal:  Nature       Date:  1976-01-22       Impact factor: 49.962

8.  Immunoglobulin synthesis by salivary gland lymphoid cells in Sjögren's syndrome.

Authors:  N Talal; R Asofsky; P Lightbody
Journal:  J Clin Invest       Date:  1970-01       Impact factor: 14.808

9.  T and B lymphocytes in peripheral blood and tissue lesions in Sjögren's syndrome.

Authors:  N Talal; R A Sylvester; T E Daniels; J S Greenspan; R C Williams
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

10.  The monoclonality of human B-cell lymphomas.

Authors:  R Levy; R Warnke; R F Dorfman; J Haimovich
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

View more
  9 in total

1.  Massive cutaneous follicular lymphoid hyperplasia in a patient with the Sjögren syndrome: 7-year follow-up and immunohistochemical study.

Authors:  Yasuhiro Horiuchi; Junichi Hakugawa; Kazuhiro Shimizu; Ichiro Katayama; Tomayoshi Hayashi; Masahiro Kikuchi
Journal:  Rheumatol Int       Date:  2006-04-20       Impact factor: 2.631

2.  Gastric pseudolymphoma. Not necessarily a benign lesion.

Authors:  J F Sweeney; C Muus; P P McKeown; A S Rosemurgy
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

3.  Expression of rheumatoid factor associated cross-reactive idiotopes by glandular B cells in Sjögren's syndrome.

Authors:  E M Deacon; J B Matthews; A J Potts; J Hamburger; R A Mageed; R Jefferis
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

Review 4.  Reactivation of Epstein-Barr virus in Sjögren's syndrome.

Authors:  R I Fox; M Luppi; H I Kang; P Pisa
Journal:  Springer Semin Immunopathol       Date:  1991

5.  Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome.

Authors:  R A Asherson; H M Fei; H L Staub; M A Khamashta; G R Hughes; R I Fox
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

6.  Multicentric Castleman's disease in a patient with primary Sjögren's syndrome.

Authors:  A Tavoni; C Vitali; P Baglioni; R Gerli; G Marchetti; O Di Munno; S Bombardieri
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

7.  Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathy.

Authors:  Katja Schenke-Layland; Jiansong Xie; Mattias Magnusson; Ekaterini Angelis; Xiaodong Li; Kaijin Wu; Dieter P Reinhardt; W Robb Maclellan; Sarah F Hamm-Alvarez
Journal:  Exp Eye Res       Date:  2009-10-21       Impact factor: 3.467

8.  A role for self-recognizing T cells in the regulation of antibody-forming and cell-mediated cytotoxic responses in the mouse.

Authors:  R M Gorczynski; M Boulanger
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

9.  Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome.

Authors:  Katja Schenke-Layland; Jiansong Xie; Ekaterini Angelis; Barry Starcher; Kaijin Wu; Iris Riemann; W Robb MacLellan; Sarah F Hamm-Alvarez
Journal:  Matrix Biol       Date:  2007-07-17       Impact factor: 11.583

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.